This study describes the discovery and characterization of a novel TREM2 antibody, which induces protective microglial functions and provides a basis for the development of human antibodies with a similar mechanistic profile for treatment of Alzheimer's disease. The gene discussed is TREM2; the disease is early-onset autosomal dominant Alzheimer disease.